Optimizing the Dosing Regimens of Tigecycline against Vancomycin-Resistant Enterococci in the Treatment of Intra-abdominal and Skin and Soft Tissue Infections

Tigecycline was previously considered to have activity against vancomycin-resistant Enterococcus (VRE) isolates, but the optimal dose was not clarified. Thus, this study assessed the in vitro activity of tigecycline against clinical VRE isolates to determine its optimal regimens for complicated intr...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Infect Chemother
Hlavní autoři: Santimaleeworagun, Wichai, Hemapanpairoa, Jatapat, Changpradub, Dhitiwat, Thunyaharn, Sudaluck
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Society of Infectious Diseases and Korean Society for Chemotherapy 2020
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7533206/
https://ncbi.nlm.nih.gov/pubmed/32989939
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3947/ic.2020.52.3.345
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky